Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Whole body MRI
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• Robot assisted laparoscopic prostatectomy
• External beam radiotherapy (EBRT)
• Stereotactic body radiation therapy (SBRT)
• Chemotherapy
• Joint specialist MDT clinic

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling
• Genetic counselling
• Onco-geriatric service

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	241	713
Performance Status recorded	33%	57%
PSA completed	8%	51%
Gleason Score completed	N/A	N/A
TNM completed	27%	27%
Stage variable assigned	32%	63%

	Specialist MDT	National
No. of men with disease status determined	453	23477
Percentage of men diagnosed with metastatic disease	11%	17%
No. of men diagnosed with M1 (metastases)	50	N/A

These indicators could not be reported this year for England as we were unable to assign a patient to a particular risk group due to the unavailability of information on Gleason score in the Rapid Cancer Registration Dataset

	Treatment Centre
No. of men who received radical prostatectomy (2020-2021)	172
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	7%
No. of men who received radical prostatectomy (2019)	221
Adjusted percentage of men experiencing at least one GU complication (%)	3%
No. of men who received radical radiotherapy (2019)	266
Adjusted percentage of men experiencing at least one GI complication (%)